- Home
- NTRS vs PODD Comparison
NTRS vs PODD Comparison
Compare NTRS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRS
- PODD
- Stock Information
- Founded
- NTRS 1889
- PODD 2000
- Country
- NTRS United States
- PODD United States
- Employees
- NTRS N/A
- PODD N/A
- Industry
- NTRS Major Banks
- PODD Medical/Dental Instruments
- Sector
- NTRS Finance
- PODD Health Care
- Exchange
- NTRS Nasdaq
- PODD Nasdaq
- Market Cap
- NTRS 23.8B
- PODD 22.1B
- IPO Year
- NTRS N/A
- PODD 2007
- Fundamental
- Price
- NTRS $127.34
- PODD $324.34
- Analyst Decision
- NTRS Hold
- PODD Strong Buy
- Analyst Count
- NTRS 15
- PODD 19
- Target Price
- NTRS $126.36
- PODD $338.79
- AVG Volume (30 Days)
- NTRS 1.2M
- PODD 522.3K
- Earning Date
- NTRS 10-22-2025
- PODD 11-06-2025
- Dividend Yield
- NTRS 2.54%
- PODD N/A
- EPS Growth
- NTRS 7.28
- PODD N/A
- EPS
- NTRS 8.58
- PODD 3.32
- Revenue
- NTRS $7,932,900,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- NTRS N/A
- PODD $29.18
- Revenue Next Year
- NTRS $3.76
- PODD $18.16
- P/E Ratio
- NTRS $14.71
- PODD $98.05
- Revenue Growth
- NTRS 0.96
- PODD 26.00
- 52 Week Low
- NTRS $81.62
- PODD $227.03
- 52 Week High
- NTRS $135.48
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- NTRS 45.15
- PODD 52.49
- Support Level
- NTRS $122.78
- PODD $320.76
- Resistance Level
- NTRS $127.46
- PODD $335.26
- Average True Range (ATR)
- NTRS 3.29
- PODD 7.05
- MACD
- NTRS -0.30
- PODD 1.24
- Stochastic Oscillator
- NTRS 49.16
- PODD 54.03
About NTRS Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.